American College of Neuropsychopharmacology
DECEMBER 3-6, 2023
Tampa, FL
CLINICAL POSTERS
The scientific posters accessible via this website have been developed and financially supported by Sumitomo Pharma America, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc.
Copies of posters obtained through this site are for personal use only and may not be reproduced without written permission from the authors.
EFFECT OF ULOTARONT ON BRAIN DOPAMINE SYNTHESIS CAPACITY IN SUBJECTS WITH SCHIZOPHRENIA ON STABLE DOSES OF A D2 ANTIPSYCHOTIC: RESULTS OF AN 18F-DOPA PET STUDY
Oliver D. Howes, Luke Vano, Grazia Rutigliano, Robert McCutcheon, Robert Lew, Snezana Milanovic, Lisa Lennek, Seth C. Hopkins, Kenneth S. Koblan
Download the PDF: CLICK HERE
Download the iPoster: CLICK HERE
EVALUATION OF THE EFFICACY AND SAFETY OF ULOTARONT IN THE TREATMENTOF SCHIZOPHRENIA: RESULTS OF TWO 6-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIALS
John M. Kane, Heather Dworak, Kenneth S. Koblan, Armin Szegedi, Robert Goldman, Yan Li, Alison Fitzgerald, Antony Loebel, Stephen R. Marder
Download the PDF: CLICK HERE
Download the iPoster: CLICK HERE